Harbor Investment Advisory, LLC Travere Therapeutics, Inc. Transaction History

Harbor Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	BUY	$18.47 - $26.14 $8,440 - $11,945	457 Added 16.37%	3,249 $0
Q3 2022 Nov 01, 2022	SELL	$22.91 - $28.63 $8,041 - $10,049	-351 Reduced 11.17%	2,792 $69,000
Q1 2022 Apr 20, 2022	SELL	$23.61 - $30.6 $6,634 - $8,598	-281 Reduced 8.21%	3,143 $81,000
Q2 2021 Jul 27, 2021	BUY	$14.11 - $26.4 $12,459 - $23,311	883 Added 34.75%	3,424 $50,000
Q1 2021 Apr 16, 2021	BUY	$23.37 - $31.77 $1,332 - $1,810	57 Added 2.29%	2,541 $63,000
Q4 2020 Feb 04, 2021	BUY	$19.17 - $27.87 $47,618 - $69,229	2,484 New	2,484 $68,000

203

85.1M

776K

912K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.35B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.